National Health Investors (NYSE:NHI - Get Free Report) will likely be announcing its Q2 2025 earnings results after the market closes on Wednesday, August 6th. Analysts expect the company to announce earnings of $1.17 per share and revenue of $86.46 million for the quarter. National Health Investors has set its FY 2025 guidance at 4.680-4.730 EPS.
National Health Investors (NYSE:NHI - Get Free Report) last posted its quarterly earnings data on Monday, May 5th. The real estate investment trust reported $1.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.13 by $0.02. National Health Investors had a net margin of 41.15% and a return on equity of 10.64%. The company had revenue of $68.87 million for the quarter, compared to the consensus estimate of $85.13 million. During the same quarter in the previous year, the firm posted $1.10 EPS. The business's revenue was up 9.6% compared to the same quarter last year. On average, analysts expect National Health Investors to post $4 EPS for the current fiscal year and $5 EPS for the next fiscal year.
National Health Investors Stock Performance
Shares of NYSE:NHI traded down $1.58 on Wednesday, hitting $69.75. 258,057 shares of the company were exchanged, compared to its average volume of 224,564. The company's 50 day moving average price is $71.23 and its two-hundred day moving average price is $71.85. National Health Investors has a one year low of $65.13 and a one year high of $86.13. The company has a debt-to-equity ratio of 0.88, a quick ratio of 16.55 and a current ratio of 16.55. The firm has a market capitalization of $3.26 billion, a price-to-earnings ratio of 22.14, a PEG ratio of 3.60 and a beta of 0.73.
National Health Investors Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, August 1st. Investors of record on Monday, June 30th will be paid a $0.90 dividend. The ex-dividend date is Monday, June 30th. This represents a $3.60 dividend on an annualized basis and a dividend yield of 5.16%. National Health Investors's payout ratio is 114.29%.
Analysts Set New Price Targets
NHI has been the subject of a number of recent research reports. Truist Financial upgraded National Health Investors from a "hold" rating to a "buy" rating and set a $77.00 target price for the company in a research note on Wednesday, July 2nd. KeyCorp upgraded National Health Investors from a "sector weight" rating to an "overweight" rating and set a $80.00 target price for the company in a research note on Thursday, July 10th. Finally, Wedbush upgraded National Health Investors to a "strong-buy" rating in a research note on Wednesday, July 2nd. Two equities research analysts have rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, National Health Investors presently has a consensus rating of "Moderate Buy" and an average price target of $84.60.
Get Our Latest Stock Analysis on National Health Investors
Institutional Inflows and Outflows
Several hedge funds have recently bought and sold shares of NHI. Jane Street Group LLC boosted its holdings in National Health Investors by 1,728.4% in the first quarter. Jane Street Group LLC now owns 69,697 shares of the real estate investment trust's stock valued at $5,148,000 after acquiring an additional 65,885 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in National Health Investors by 9.6% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 249,937 shares of the real estate investment trust's stock valued at $18,460,000 after acquiring an additional 21,851 shares during the last quarter. Finally, NewEdge Advisors LLC boosted its holdings in National Health Investors by 28.7% in the first quarter. NewEdge Advisors LLC now owns 1,546 shares of the real estate investment trust's stock valued at $114,000 after acquiring an additional 345 shares during the last quarter. 62.51% of the stock is currently owned by institutional investors and hedge funds.
About National Health Investors
(
Get Free Report)
Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
Recommended Stories
Before you consider National Health Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Health Investors wasn't on the list.
While National Health Investors currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
